|
Website Launched! |
|
|
Monday, 27 February 2006 |
|
We are glad to present our new corporate website. |
|
|
Novartis wins approval letter from FDA for Aclasta to treat Paget's disease |
|
|
Thursday, 23 February 2006 |
|
ZURICH (AFX) - Novartis AG last Friday said it has received an approvable letter from the US Food and Drug Administration for zoledronic acid, known under the trade name of Aclasta, which is under review for the treatment of Paget's disease of the bone. |
|
Read more...
|
|
|
